[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hirsh et al., 1980 - Google Patents

Acquired hypomegakaryocytic thrombocytopenic purpura: occurrence in a patient with absent thrombopoietic stimulating factor

Hirsh et al., 1980

Document ID
117935997008560130
Author
Hirsh E
Vogler W
McDonald T
Stein S
Publication year
Publication venue
Archives of Internal Medicine

External Links

Snippet

• A 49-year-old woman had purpura and thrombocytopenia not associated with drugs or identifiable underlying disease. The platelet survival was normal and the marrow showed a sharp reduction in megakaryocytes with preservation of other cell lines. There was no …
Continue reading at jamanetwork.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated

Similar Documents

Publication Publication Date Title
Price et al. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans
Katz et al. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma
Kasahara et al. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)–mediated apoptosis of neutrophils
ZELLER et al. Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis
Klokker et al. Influence of in vivo hypobaric hypoxia on function of lymphocytes, neutrocytes, natural killer cells, and cytokines
Appelbaum et al. Treatment of aplastic anemia by bone marrow transplantation in identical twins
Jarrold et al. Hematologic observations in patients with chronic hepatic insufficiency: sternal bone marrow morphology and bone marrow plasmacytosis
Barak et al. In vitro induction of myeloid proliferation and maturation in infantile genetic agranulocytosis
Meyer et al. Autoimmune hemolytic anemia and periodic pure red cell aplasia in systemic lupus erythematosus
Ferreira et al. Insulin modulates the immune cell phenotype in pulmonary allergic inflammation and increases pulmonary resistance in diabetic mice
Heath Jr et al. The Philadelphia chromosome in an unusual case of myeloproliferative disease
Hirsh et al. Acquired hypomegakaryocytic thrombocytopenic purpura: occurrence in a patient with absent thrombopoietic stimulating factor
MARENGO-ROWE et al. Hemophilia-like disease associated with pregnancy
Baker et al. Mechanism of action of serum factors that regulate granulopoiesis in vitro: possible physiologic role of serum-inhibiting activity
Lipschitz Nutrition, aging, and the immunohematopoietic system
JP4443935B2 (en) Cell competence testing to predict hematopoietic recovery, neutropenic fever, and antibacterial treatment after high-dose cytotoxic chemotherapy
Horowitz et al. Survival of factor XI in vitro and in vivo
SEIP Hereditary hypoplastic thrombocytopenia
Cigni et al. Fatal Aeromonas hydrophila septicemia in a 16-year-old patient with thalassemia
Panch et al. Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency
Perillie Studies of the changes in leukocyte alkaline phosphatase following pyrogen stimulation in chronic granulocytic leukemia
Suda et al. Suppression of in vitro granulocyte‐macrophage colony formation by the peripheral mononuclear phagocytic cells of patients with idiopathic aplastic anaemia
Hays Physiology of normal bone marrow
McDonald et al. Effects of thrombopoietin and erythropoietin on platelet production in rebound‐thrombocytotic and normal mice
Dickerman Transient erythroblastopenia of childhood presenting with reticulocytosis and erythroid hyperplasia in the bone marrow